Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD34 selected alloPBSCT and adoptive immunotherapy.

W Knauf1, T Fietz, H Schrezenmeier

  • 1Medizinische Klinik III, Universitätsklinik Benjamin Franklin, Freie Universität Berlin, Germany.

Bone Marrow Transplantation
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo.

Leukemia & lymphoma·2016
Same author

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Leukemia & lymphoma·2016
Same author

Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry.

Internal medicine journal·2016
Same author

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Leukemia·2016
Same author

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Bone marrow transplantation·2016
Same author

[Aplastic anemia: Current state of diagnosis and treatment].

Der Internist·2015

This study explored a novel approach to allogeneic stem cell transplantation by using CD34+ selected grafts and delayed T cell add-back to prevent early graft-versus-host disease while preserving graft-versus-leukemia activity. Results show feasibility and rapid engraftment, suggesting potential for improved transplant outcomes.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Allogeneic stem cell transplantation (allo-SCT) faces challenges in balancing graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects.
  • Early GVHD can be mitigated, but preserving GVL activity remains crucial for long-term patient survival.

Purpose of the Study:

  • To investigate a strategy of CD34+ selected peripheral blood stem cell transplantation (alloPBSCT) followed by delayed CD3+ T cell add-back.
  • To circumvent acute GVHD (aGVHD) in the early post-transplant phase while enabling GVL activity later on.

Main Methods:

  • Ten patients with hematologic malignancies received alloPBSCT from HLA-identical siblings after conditioning with cyclophosphamide (CY) and total body irradiation (TBI).
  • Peripheral blood stem cells were selected for CD34+ purity, with a median purity of 86%.

Related Experiment Videos

  • A delayed T cell add-back of CD3+ cells was administered on day +60 post-transplant, with concurrent immunosuppression tapering.

    • Main Results:

    • All patients achieved rapid engraftment, and no aGVHD occurred by day +60 with standard-dose cyclosporine A (CsA).
    • The delayed T cell add-back was feasible, although one patient developed fatal intestinal aGVHD after a second T cell boost without immunosuppression.
    • Three patients developed cutaneous chronic GVHD (cGVHD).

    Conclusions:

    • CD34+ selection effectively minimizes early aGVHD without compromising rapid engraftment in HLA-identical sibling allo-SCT.
    • Delayed T cell add-back is feasible but requires further optimization regarding timing and cell dose to balance GVL and GVHD.
    • This approach holds promise for improving allo-SCT outcomes by managing GVHD and preserving GVL effects.